BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32156927)

  • 1. [A Case of Solitary Residual Lateral Pelvic Lymph Node Metastasis Despite Complete Response of Primary Rectal Cancer Followed by Neoadjuvant Chemoradiotherapy].
    Tayama H; Karasawa H; Kajiwara T; Ohnuma S; Suzuki H; Kohyama A; Watanabe K; Ishida T; Kamei T; Naitoh T; Unno M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2348-2350. PubMed ID: 32156927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
    Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
    Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Laparoscopically Resected Giant Rectal Cancer Following Neoadjuvant Chemoradiotherapy].
    Aizawa T; Karasawa H; Ohnuma S; Suzuki H; Imoto H; Yamamura A; Kohyama A; Aoki T; Watanabe K; Tanaka N; Musha H; Motoi F; Kamei T; Naitoh T; Unno M
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1931-1933. PubMed ID: 30692401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of pathological complete response to lt. Lateral lymph node metastasis from lower rectal cancer by S-1 combined neoadjuvant chemoradiotherapy].
    Kimura S; Ohnuma S; Karasawa H; Aoki T; Kudoh K; Watanabe K; Tanaka N; Nagao M; Abe T; Musha H; Morikawa T; Motoi F; Katayose Y; Naitoh T; Unno M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1560-2. PubMed ID: 25731252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.
    Atef Y; Koedam TW; van Oostendorp SE; Bonjer HJ; Wijsmuller AR; Tuynman JB
    World J Surg; 2019 Dec; 43(12):3198-3206. PubMed ID: 31468119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of lateral pelvic lymph node metastasis of T1 lower rectal cancer using diffusion-weighted magnetic resonance imaging: A case report with lateral pelvic lymph node dissection of lower rectal cancer.
    Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Okamoto T
    Mol Clin Oncol; 2016 May; 4(5):817-820. PubMed ID: 27123286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients.
    Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Chun HK
    Int J Colorectal Dis; 2014 Feb; 29(2):193-200. PubMed ID: 24322736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
    Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
    Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer.
    Fujita S; Yamamoto S; Akasu T; Moriya Y
    Int J Colorectal Dis; 2009 Sep; 24(9):1085-90. PubMed ID: 19387660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.
    Ogawa S; Hida JI; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Yamamoto M; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2017 Oct; 32(10):1479-1487. PubMed ID: 28762189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
    Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
    Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H
    Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Tech Coloproctol; 2018 May; 22(5):347-354. PubMed ID: 29623475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?
    Ahmadi N; Brown KGM; Lee P; Quinn M; Austin KKS; Solomon MJ
    Colorectal Dis; 2020 Jun; 22(6):689-693. PubMed ID: 31909851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.
    Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K
    Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.